These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 27371875)

  • 1. Advances and challenges in understanding histone demethylase biology.
    Nowak RP; Tumber A; Johansson C; Che KH; Brennan P; Owen D; Oppermann U
    Curr Opin Chem Biol; 2016 Aug; 33():151-9. PubMed ID: 27371875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of enzymes catalyzing modifications to histone lysine residues: structure, function and activity.
    Lillico R; Stesco N; Khorshid Amhad T; Cortes C; Namaka MP; Lakowski TM
    Future Med Chem; 2016 May; 8(8):879-97. PubMed ID: 27173004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future therapeutic potential of histone demethylases: A critical analysis.
    Natoli G; Testa G; De Santa F
    Curr Opin Drug Discov Devel; 2009 Sep; 12(5):607-15. PubMed ID: 19736620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histone demethylases in chromatin biology and beyond.
    Dimitrova E; Turberfield AH; Klose RJ
    EMBO Rep; 2015 Dec; 16(12):1620-39. PubMed ID: 26564907
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessing histone demethylase inhibitors in cells: lessons learned.
    Hatch SB; Yapp C; Montenegro RC; Savitsky P; Gamble V; Tumber A; Ruda GF; Bavetsias V; Fedorov O; Atrash B; Raynaud F; Lanigan R; Carmichael L; Tomlin K; Burke R; Westaway SM; Brown JA; Prinjha RK; Martinez ED; Oppermann U; Schofield CJ; Bountra C; Kawamura A; Blagg J; Brennan PE; Rossanese O; Müller S
    Epigenetics Chromatin; 2017; 10():9. PubMed ID: 28265301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Histone Lysine Demethylase Inhibitors.
    Jambhekar A; Anastas JN; Shi Y
    Cold Spring Harb Perspect Med; 2017 Jan; 7(1):. PubMed ID: 28049654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of histone demethylases in cancer therapy.
    Hoffmann I; Roatsch M; Schmitt ML; Carlino L; Pippel M; Sippl W; Jung M
    Mol Oncol; 2012 Dec; 6(6):683-703. PubMed ID: 22902149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tackling malignant melanoma epigenetically: histone lysine methylation.
    Orouji E; Utikal J
    Clin Epigenetics; 2018 Nov; 10(1):145. PubMed ID: 30466474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The emerging therapeutic potential of histone methyltransferase and demethylase inhibitors.
    Spannhoff A; Hauser AT; Heinke R; Sippl W; Jung M
    ChemMedChem; 2009 Oct; 4(10):1568-82. PubMed ID: 19739196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Targeting Histone Methylation in Cancer.
    McCabe MT; Mohammad HP; Barbash O; Kruger RG
    Cancer J; 2017; 23(5):292-301. PubMed ID: 28926430
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting LSD1 in cancer: Molecular elucidation and recent advances.
    Cai W; Xiao C; Fan T; Deng Z; Wang D; Liu Y; Li C; He J
    Cancer Lett; 2024 Aug; 598():217093. PubMed ID: 38969160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting histone lysine methylation in cancer.
    McGrath J; Trojer P
    Pharmacol Ther; 2015 Jun; 150():1-22. PubMed ID: 25578037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression, Purification, and Biochemical Analysis of the LSD1/KDM1A Histone Demethylase.
    Laurent B; Shi Y
    Methods Enzymol; 2016; 573():241-59. PubMed ID: 27372756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The role of demethylases in cardiac development and disease.
    Davis K; Azarcon P; Hickenlooper S; Bia R; Horiuchi E; Szulik MW; Franklin S
    J Mol Cell Cardiol; 2021 Sep; 158():89-100. PubMed ID: 34081951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting histone methyltransferases and demethylases in clinical trials for cancer therapy.
    Morera L; Lübbert M; Jung M
    Clin Epigenetics; 2016; 8():57. PubMed ID: 27222667
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Small molecule epigenetic inhibitors targeted to histone lysine methyltransferases and demethylases.
    Wang Z; Patel DJ
    Q Rev Biophys; 2013 Nov; 46(4):349-73. PubMed ID: 23991894
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone lysine methylation dynamics: establishment, regulation, and biological impact.
    Black JC; Van Rechem C; Whetstine JR
    Mol Cell; 2012 Nov; 48(4):491-507. PubMed ID: 23200123
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncoepigenomics: making histone lysine methylation count.
    Decarlo D; Hadden MK
    Eur J Med Chem; 2012 Oct; 56():179-94. PubMed ID: 22975593
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trends of LSD1 inhibitors in viral infections.
    Zwergel C; Stazi G; Mai A; Valente S
    Future Med Chem; 2018 May; 10(10):1133-1136. PubMed ID: 29787289
    [No Abstract]   [Full Text] [Related]  

  • 20. Development of homogeneous nonradioactive methyltransferase and demethylase assays targeting histone H3 lysine 4.
    Gauthier N; Caron M; Pedro L; Arcand M; Blouin J; Labonté A; Normand C; Paquet V; Rodenbrock A; Roy M; Rouleau N; Beaudet L; Padrós J; Rodriguez-Suarez R
    J Biomol Screen; 2012 Jan; 17(1):49-58. PubMed ID: 21940714
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.